On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 09/16/22
- Uber says no evidence breach involved sensitive user data
- 09/16/22
- Uber down 4% in pre-market amid investigation of cybersecurity breach
- 09/16/22
- Uber currently responding to cybersecurity incident
- 09/13/22
- Uber pays NJ $100M for improperly classifying independent contractors
- 09/15/22
- Texas Instruments raises dividend 8%, announces $15B share buyback program
- 09/15/22
- Texas Instruments raises dividend 8%, announces $15B share buyback program
- 07/26/22
- Texas Instruments jumps 3.5% to $166.50 after Q2 earnings beat
- 07/26/22
- Texas Instruments sees 2022 effective tax rate about 14%
- 04/28/22
- Travel + Leisure board approves $500M increase to share repurchase plan
- 08/15/22
- Shoals Technologies names Dominic Bardos as CFO
- 08/11/22
- Shoals Technologies group awarded 53.4 MWdc Honduras Solar Project
- 06/06/22
- President Biden announces executive action on clean energy technologies
- 04/08/22
- Shoals Technologies CFO Philip Garton to depart, Kevin Hubbard named interim CFO
- 08/04/22
- Robinhood CEO says in 'great position as a stand-alone company'
- 08/02/22
- TD Bank to acquire Cowen in cash transaction valued at $1.3B or $39 per share
- 08/02/22
- Charles Schwab repurchases $1B of shares from Toronto-Dominion
- 08/01/22
- TD Bank Group sells 28.4M shares of Schwab common stock
- $707.87 /
+1.895 (+0.27%) - 09/16/22
- Intellia, Regeneron announce initial data from Phase 1 study of NTLA-2001
- 09/16/22
- Intellia Therapeutics, Regeneron report results of Phase 1 study of NTLA-2001
- 09/15/22
- Regeneron discloses Dupixent results in children published in Lancet
- 09/15/22
- Longeveron names Bailey as Vice President of Business Operations
- $118.58 /
-14.24 (-10.72%) - 05/18/22
- Packaging Corp. raises quarterly dividend by 25% to $1.25 per share
- 09/16/22
- BioNTech, Pfizer receive positive CHMP opinion of COMIRNATY
- 09/15/22
- Pfizer's meningococcal vaccine meets Phase 3 immunogenicity, safety endpoints
- 09/14/22
- Pfizer begins Phase 3 study of mRNA-based influenza vaccine
- 09/13/22
- Pfizer and Strata Oncology expand clinical collaboration in early-stage cancer
- 09/16/22
- NCR Corp. falls -23.4%
- 09/16/22
- NCR Corp. falls -23.6%
- 09/16/22
- NCR Corp. falls -21.2%
- 09/15/22
- NCR Corp. to separate into two separate digital commerce and ATM companies
- 09/16/22
- Merck announces CHMP recommendation for approval of Vaxneuvance
- 09/15/22
- Syapse enters collaboration with Merck to better understand cancers
- 09/13/22
- Merck: Health Canada approves KEYTRUDA for treatment of stage IIB, IIC melanoma
- 09/13/22
- Medicenna announces clinical collaboration with Merck on MDNA11 with KEYTRUDA
- 09/15/22
- Meta Platforms' Instagram to allow payments capability within its messages
- 09/14/22
- Amazon says tools can help sellers reach more shoppers on Facebook, Instagram
- 09/13/22
- Facebook debuts Community Chats to connect your community on Messenger
- 05/12/22
- International Paper general counsel Sharon Ryan to retire, Joe Saab to succeed
- 09/16/22
- Huntsman drops 6% to $24.95 after lowering Q3 adjusted EBITDA view
- 08/12/22
- Starboard Value exits ZeroFox, boosts Mercury Systems in Q2
- 08/09/22
- Huntsman to sell Textile Effects division to Archroma for $718M
- 05/13/22
- Starboard takes stake in Humana, exits System1
- 09/09/22
- GSK says Zejula shows durable and sustained long-term PFS benefit in PRIMA study
- 09/07/22
- SpringsWorks Therapeutics expands global collaboration with GSK
- 09/06/22
- GSK plc says FDA to convene advisory committee to review daprodustat NDA
- 09/06/22
- GSK plc announces WHO grants prequalification to Mosquirix malaria vaccine
- 09/15/22
- Goldman Sachs AM, Cleanhill Partners acquire majority stake in EPC Power Corp.
- 08/04/22
- Goldman Sachs says CFPB investigating credit card practices
- 07/20/22
- BNY Mellon, Goldman Sachs complete lending transactions using HQLAX DLT platform
- 07/18/22
- Goldman Sachs CEO: We're extremely client centered
- 09/15/22
- SkyWater Technology to manufacture chips for NIST, Google partnership
- 09/14/22
- Google, Meta fined over $70M for privacy violations in South Korea
- 09/14/22
- EU court upholds antitrust ruling against Google, reduces fine to EUR 4.125B
- 09/13/22
- NIST, Google to create new chip supply for researchers, tech startups
- 09/16/22
- Gogo to repurchase 1.5M shares of common stock owned by BlackRock
- 07/22/22
- Gogo's nationwide 5G network construction halfway complete
- 04/08/22
- Gogo to replace SPX Flow in S&P 600 at open on 4/8
- 04/06/22
- Gogo rallies after S&P announces SmallCap 600 index addition
- 09/15/22
- FirstEnergy CEO Steven Strah to retire
- 08/15/22
- Icahn buys Bausch + Lomb, exits Delek in Q2
- 08/15/22
- FirstEnergy closes ash landfill in West Virginia, to be used for solar program
- 05/13/22
- Icahn buys International Flavors, cuts Cheniere Energy in Q1
- $161.26 /
-43.74 (-21.34%) - 09/16/22
- FedEx falls -23.1%
- 09/16/22
- FedEx falls -23.4%
- 09/16/22
- FedEx falls -23.4%
- 09/15/22
- FedEx CEO: Demand in Asia is weak
- 09/16/22
- Extra Space Storage acquires Storage Express for $590M
- 09/13/22
- Citi CFO comments on Q3 performance at conference
- 09/13/22
- Citi CFO says no change to full year revenue guidance
- 09/06/22
- Delek US expands leadership team, adds Hobbs as EVP, Corporate Development
- 07/27/22
- Citi raises base lending rate to 5.5%
- 09/07/22
- Bowlero acquires three bowling centers in Texas, Florida
- 08/30/22
- Bowlero rises 9.1%
- 05/31/22
- Bowlero acquires bowling centers in Florida, Colorado
- 05/23/22
- Bowlero announces agreement to acquire three bowling centers in Kansas
- 08/11/22
- BlackRock launches spot bitcoin private trust
- 08/04/22
- Coinbase jumps 34% to $108.46 after announcing partnership with BlackRock
- 08/04/22
- Coinbase selected by BlackRock for crypto trading access
- 09/15/22
- Arrow Electronics announces $600M share repurchase program
- 08/16/22
- Western Union announces departure of CFO Raj Agrawal to Arrow Electronics
- 08/16/22
- Arrow Electronics names Rajesh Agrawal CFO
- 08/02/22
- Netreo signs Arrow Electronics as distributor
ALHC Alignment Healthcare - 09/15/22
- Alignment Healthcare drops 6% to $15.00 after 9M share stock offering
- 09/06/22
- Alignment Healthcare completes debt refinancing
- 08/12/22
- Alignment Healthcare CEO Kao sells 500,000 common shares
- 08/03/22
- Alignment Healthcare issues inaugural ESG report
- 09/16/22
- ADiTx Therapeutics trading resumes
- 09/16/22
- ADiTx Therapeutics trading halted, volatility trading pause
- 09/14/22
- ADiTx Therapeutics trading resumes
- 09/14/22
- ADiTx Therapeutics trading halted, volatility trading pause
- 09/15/22
- Adobe expects Figma transaction to be accretive at end of year three
- 09/15/22
- Adobe says Figma acquisition 'couldn't come at better time'
- 09/15/22
- Adobe to acquire Figma for $20B in cash, stock
- 09/15/22
- Adobe to acquire Figma for $20B in cash and stock
- 09/14/22
- Alcoa falls -9.3%
- 09/08/22
- Alcoa receives certification from the ASI
- 08/28/22
- Fly Intel: Top five weekend stock stories
- 08/22/22
- Strike commences at Alcoa's Mosjoen smelter in Norway
- $161.26 /
-43.74 (-21.34%) - 09/16/22 UBS
- FedEx price target lowered to $232 from $308 at UBS
- 09/16/22 Evercore ISI
- FedEx price target lowered to $243 from $318 at Evercore ISI
- 09/16/22 Wells Fargo
- FedEx price target lowered to $199 from $269 at Wells Fargo
- 09/16/22 Cowen
- FedEx price target lowered to $230 from $310 at Cowen
- 07/27/22 Baird
- CHIPS Act could have deflationary impact on semiconductors, says Baird
- 07/27/22 Deutsche Bank
- Texas Instruments price target raised to $165 from $160 at Deutsche Bank
- 07/27/22 Mizuho
- Texas Instruments price target lowered to $168 from $175 at Mizuho
- 07/27/22 Citi
- Texas Instruments price target raised to $165 from $160 at Citi
- 04/27/22 RBC Capital
- NCR Corp. price target lowered to $44 from $54 at RBC Capital
- 04/27/22 Morgan Stanley
- NCR Corp. price target lowered to $40 from $61 at Morgan Stanley
- 01/03/22 Stephens
- Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
- 11/18/21 Stephens
- NCR Corp. initiated with an Overweight at Stephens
- 09/12/22 Wedbush
- Wedbush raises Wingstop price target to $157, removes from Best Ideas List
- 09/06/22 BofA
- BofA starts Lyft at Underperform with $14 price target
- 08/23/22 Wolfe Research
- Uber remains top idea in mobility at Wolfe Research
- 08/05/22 Wedbush
- Uber's June quarter a step in the right direction, says Wedbush
- 08/15/22 Truist
- Extra Space Storage price target raised to $225 from $200 at Truist
- 06/30/22 Jefferies
- Extra Space Storage price target lowered to $184 from $228 at Jefferies
- 06/22/22 JPMorgan
- Extra Space Storage upgraded to Overweight from Neutral at JPMorgan
- 06/01/22 Truist
- Extra Space Storage price target lowered to $200 from $225 at Truist
- 09/16/22 Morgan Stanley
- Alcoa upgraded to Overweight from Equal Weight at Morgan Stanley
- 07/25/22 Morgan Stanley
- Alcoa price target lowered to $51 from $55 at Morgan Stanley
- 07/21/22 BMO Capital
- Alcoa price target lowered to $55 from $57 at BMO Capital
- 07/19/22 Credit Suisse
- Alcoa price target lowered to $63 from $82 at Credit Suisse
- 09/16/22 Jefferies
- International Paper downgraded to Underperform from Hold at Jefferies
- 08/01/22 Jefferies
- Jefferies sees increased risk of International Paper, WestRock prices falling
- 07/19/22 Deutsche Bank
- International Paper price target lowered to $44 from $48 at Deutsche Bank
- 07/18/22 Wells Fargo
- Wells Fargo downgrades International Paper to Equal Weight
- $118.58 /
-14.24 (-10.72%) - 09/16/22 Jefferies
- Packaging Corp. downgraded to Underperform from Hold at Jefferies
- 07/27/22 Wells Fargo
- Packaging Corp. price target lowered to $143 from $154 at Wells Fargo
- 07/27/22 Citi
- Packaging Corp. price target raised to $147 from $144 at Citi
- 07/19/22 Deutsche Bank
- Packaging Corp. price target lowered to $144 from $158 at Deutsche Bank
- 09/16/22 Evercore ISI
- Adobe price target lowered to $350 from $475 at Evercore ISI
- 09/16/22 BMO Capital
- Adobe price target lowered to $345 from $435 at BMO Capital
- 09/16/22 Cowen
- Adobe price target lowered to $400 from $520 at Cowen
- 09/16/22 Credit Suisse
- Adobe price target lowered to $350 from $425 at Credit Suisse
- 09/16/22 Wells Fargo
- Arrow downgraded to Underweight on weakening demand at Wells Fargo
- 09/16/22 Wells Fargo
- Arrow Electronics downgraded to Underweight from Equal Weight at Wells Fargo
- 07/15/22 Goldman Sachs
- Arrow Electronics price target lowered to $127 from $158 at Goldman Sachs
- 04/08/22 Truist
- Arrow Electronics price target lowered to $126 from $143 at Truist
- 09/16/22 Cowen
- Cowen upgrades Shoals to Outperform, sees 'compelling opportunity'
- 09/16/22 Cowen
- Shoals Technologies upgraded to Outperform from Market Perform at Cowen
- 09/09/22 Guggenheim
- Shoals downgraded to Neutral on valuation at Guggenheim
- 09/09/22 Guggenheim
- Shoals Technologies downgraded to Neutral from Buy at Guggenheim
- 09/12/22 Deutsche Bank
- Goldman Sachs price target lowered to $370 from $430 at Deutsche Bank
- 09/06/22 Odeon Capital
- Goldman Sachs downgraded to Sell from Hold at Odeon Capital
- 07/19/22 BMO Capital
- Goldman Sachs price target lowered to $461 from $475 at BMO Capital
- 07/19/22 Barclays
- Goldman Sachs price target lowered to $450 from $505 at Barclays
- 08/22/22 Evercore ISI
- Evercore says Apple getting NFL Sunday Ticket rights makes sense
- 08/10/22 Oppenheimer
- Trade Desk price target raised to $78 from $60 at Oppenheimer
- 08/09/22 Stifel
- Unity price target raised to $60 at Stifel after AppLovin proposal
- 08/03/22 Tigress Financial
- Alphabet price target raised to $186 from $183 at Tigress Financial
- 08/10/22 BofA
- Meta Platforms added to US 1 List; Alphabet removed at BofA
- 08/10/22 Needham
- Trade Desk price target raised to $65 from $55 at Needham
- 09/15/22 Credit Suisse
- GSK upgraded to Neutral from Underperform at Credit Suisse
- 09/13/22 Truist
- AnaptysBio cut to Hold at Truist with price target of $28
- 09/08/22 Jefferies
- GSK downgraded to Hold from Buy at Jefferies
- 09/07/22 Deutsche Bank
- GSK plc price target lowered to 1,500 GBp from 1,750 GBp at Deutsche Bank
- $707.87 /
+1.895 (+0.27%) - 09/16/22 Canaccord
- Regeneron price target raised to $750 from $700 at Canaccord
- 09/13/22 Piper Sandler
- Regeneron price target raised to $775 from $692 at Piper Sandler
- 09/12/22 Piper Sandler
- Regeneron data at ESMO showcases 'power' of oncology pipeline, says Piper
- 09/12/22 Guggenheim
- Regeneron price target raised to $925 from $740 at Guggenheim
- 09/13/22 Morgan Stanley
- Total U.S. time spent on Meta down 3% year/year in August, says Morgan Stanley
- 09/12/22 Piper Sandler
- Meta Platforms price target lowered to $175 from $190 at Piper Sandler
- 08/22/22 Loop Capital
- Meta Platforms price target lowered to $165 from $180 at Loop Capital
- 08/22/22 Loop Capital
- Enovix price target raised to $100 from $50 at Loop Capital
- 09/12/22 Deutsche Bank
- Citi price target lowered to $52 from $55 at Deutsche Bank
- 09/06/22 Odeon Capital
- Citi downgraded to Hold from Buy at Odeon Capital
- 07/18/22 Oppenheimer
- Citi price target raised to $86 from $81 at Oppenheimer
- 07/18/22 UBS
- Citi price target raised to $52 from $48 at UBS
- 09/13/22 Truist
- Concert Pharmaceuticals price target raised to $25 from $22 at Truist
- 09/02/22 Cantor Fitzgerald
- Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
- 08/26/22 Citi
- Citi opens 'positive catalyst watches' on GSK, Sanofi after Zantac ruling
- 08/18/22 Piper Sandler
- Biohaven downgraded to Neutral from Overweight at Piper Sandler
- 09/08/22 William Blair
- William Blair says buy Iridium on selloff from Apple, Globalstar pact
- 05/24/22 William Blair
- Gogo pact with Echostar doubles addressable market, says William Blair
- 04/26/22 Northland
- SpaceX's Starlink deal with Hawaiian highlights risk for Gogo, says Northland
- 03/24/22 William Blair
- Gogo shares headed to low $30s by 2024, says William Blair
- 09/14/22 Berenberg
- Merck upgraded to Buy from Hold at Berenberg
- 08/25/22 Erste Group
- Merck upgraded to Buy from Hold at Erste Group
- 08/18/22 Wells Fargo
- Sutro Biopharma assumed with an Overweight at Wells Fargo
- 08/17/22 Barclays
- Gossamer Bio price target raised to $18 from $12 at Barclays
- 08/12/22 Deutsche Bank
- BlackRock price target raised to $860 from $720 at Deutsche Bank
- 08/04/22 JMP Securities
- JMP 'encouraged' by Coinbase partnership with BlackRock's Aladdin
- 07/18/22 Deutsche Bank
- BlackRock price target lowered to $720 from $725 at Deutsche Bank
- 07/13/22 Deutsche Bank
- BlackRock price target lowered to $725 from $747 at Deutsche Bank
- 09/16/22 Dawson James
- Aditx Therapeutics downgraded to Neutral from Buy at Dawson James
- 12/23/21
- Aditx Therapeutics price target raised to $6 from $4 at Dawson James
ALHC Alignment Healthcare - 09/08/22 Piper Sandler
- Alignment Healthcare assumed with an Overweight at Piper Sandler
- 08/22/22 Cowen
- Alignment Healthcare price target raised to $17 from $12 at Cowen
- 08/08/22 UBS
- Alignment Healthcare price target raised to $17 from $11 at UBS
- 08/08/22 Barclays
- Alignment Healthcare price target raised to $21 from $14 at Barclays
- 09/12/22 Credit Suisse
- Huntsman initiated with an Outperform at Credit Suisse
- 08/11/22 RBC Capital
- Huntsman price target raised to $43 from $39 at RBC Capital
- 08/04/22 Citi
- Huntsman price target lowered to $34 from $35 at Citi
- 08/03/22 Deutsche Bank
- Huntsman price target lowered to $35 from $40 at Deutsche Bank
- 09/16/22 Morgan Stanley
- FirstEnergy overhangs getting resolved, says Morgan Stanley
- 07/18/22 Barclays
- FirstEnergy price target lowered to $41 from $49 at Barclays
- 06/07/22 Mizuho
- FirstEnergy estimates lowered on higher costs at Mizuho
- 05/16/22 BofA
- FirstEnergy downgraded to Neutral from Buy at BofA
- 09/16/22 UBS
- Charles Schwab price target raised to $85 from $82 at UBS
- 08/31/22 Barclays
- Charles Schwab initiated with an Equal Weight at Barclays
- 08/19/22 Deutsche Bank
- Charles Schwab price target raised to $95 from $90 at Deutsche Bank
- 08/12/22 Deutsche Bank
- Charles Schwab price target raised to $90 from $83 at Deutsche Bank
- 08/12/22 Truist
- Travel + Leisure price target lowered to $72 from $78 at Truist
- 08/01/22 Deutsche Bank
- Travel + Leisure price target lowered to $69 from $76 at Deutsche Bank
- 07/28/22 Stifel
- Travel + Leisure price target lowered to $61 from $76 at Stifel
- 06/28/22 Barclays
- Travel + Leisure initiated with an Equal Weight at Barclays
- 09/16/22 JPMorgan
- Bowlero price target raised to $18 from $17 at JPMorgan
- 09/16/22 MKM Partners
- Bowlero price target raised to $17 from $14 at MKM Partners
- 08/30/22 JPMorgan
- JPMorgan starts Bowlero at Overweight on 'economically-attractive' industry
- 08/30/22 JPMorgan
- Bowlero initiated with an Overweight at JPMorgan
- 08/02/22
- Uber reports Q2 EPS ($1.33), consensus (26c)
- 08/01/22
- Notable companies reporting before tomorrow's open
- 05/04/22
- Uber reports Q1 EPS ($3.04), consensus (24c)
- 07/26/22
- Texas Instruments sees Q3 EPS $2.23-$2.51, consensus $2.26
- 07/26/22
- Texas Instruments reports Q2 EPS $2.45, consensus $2.12
- 07/26/22
- Notable companies reporting after market close
- 04/26/22
- Texas Instruments sees Q2 EPS $1.84-$2.26, consensus $2.27
- 09/15/22
- Travel + Leisure backs Q3 adjusted EBITDA view $230M-$240M
- 07/28/22
- Travel + Leisure sees FY22 adjusted EBITDA $860M-$880M
- 07/28/22
- Travel + Leisure sees Q3 adjusted EBITDA $230M-$240M
- 07/28/22
- Travel + Leisure reports Q2 adjusted EPS $1.27, consensus $1.19
- 08/15/22
- Shoals Technologies sees FY22 revenue $300M-$325M, consensus $312.58M
- 08/15/22
- Shoals Technologies reports Q2 EPS 4c, consensus 7c
- 05/16/22
- Shoals Technologies narrows FY22 revenue view to $300M-$325M from $300M-$350M
- 05/16/22
- Shoals Technologies reports Q1 adjusted EPS 5c, consensus 7c
- 09/16/22
- Charles Schwab sees Q3 revenue up 18%-19% y/y
- 07/28/22
- Charles Schwab sees FY22 revenue up 11%-13% y/y, consensus $20.59B
- 07/18/22
- Charles Schwab reports Q2 adjusted EPS 97c vs. 70c last year
- 04/18/22
- Charles Schwab reports Q1 EPS 77c, consensus 84c
- $707.87 /
+1.895 (+0.27%) - 08/03/22
- Regeneron reports Q2 EPS $9.77, consensus $9.54
- 05/04/22
- Regeneron reports Q1 EPS $11.49, consensus $9.89
- $118.58 /
-14.24 (-10.72%) - 07/25/22
- Packaging Corp. sees Q3 EPS $2.80, consensus $3.13
- 07/25/22
- Packaging Corp. reports Q2 adjusted EPS $3.23, consensus $2.85
- 04/25/22
- Packaging Corp. reports Q1 EPS ex-items, $2.72, consensus $2.51
- 07/28/22
- Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45
- 07/28/22
- Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80
- 07/27/22
- NCR Corp. reports Q2 EPS 71c, consensus 61c
- 04/26/22
- NCR Corp. lowers FY22 adjusted EPS view $2.70-$3.20 from $3.25-$3.55
- 04/26/22
- NCR Corp. reports Q1 adjusted EPS 33c, consensus 63c
- 07/28/22
- Merck narrows FY22 adjusted EPS view to $7.25-$7.35 from $7.24-$7.36
- 07/28/22
- Merck reports Q2 adjusted EPS $1.87, consensus $1.69
- 07/27/22
- Meta Platforms reports Q2 EPS $2.46, consensus $2.61
- 07/27/22
- Notable companies reporting after market close
- 07/28/22
- International Paper reports Q2 adjusted EPS $1.24, consensus $1.08
- 07/27/22
- Notable companies reporting before tomorrow's open
- 04/28/22
- International Paper reports Q1 adjusted EPS 76c, consensus 51c
- 09/16/22
- Huntsman cuts Q3 adjusted EBITDA view to $260M-$280M from $310M-$355M
- 08/02/22
- Huntsman reports Q2 adjusted EPS $1.28, consensus $1.15
- 04/28/22
- Huntsman reports Q1 adjusted EPS $1.19, consensus $1.03
- 07/27/22
- GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year
- 04/27/22
- GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER
- 04/27/22
- GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year
- 04/13/22
- GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B
- 07/18/22
- Goldman Sachs reports Q2 EPS $7.73, consensus $7.25
- 04/14/22
- Goldman Sachs reports Q1 EPS $10.76, consensus $8.82
- 04/13/22
- Notable companies reporting before tomorrow's open
- 07/26/22
- Alphabet reports Q2 EPS $1.21, consensus $1.30
- 04/26/22
- Alphabet reports Q1 EPS $24.62, consensus $25.96
- 04/26/22
- Notable companies reporting after market close
- 08/05/22
- Gogo updates long-term financial targets
- 08/05/22
- Gogo sees FY22 revenue at 'high end' of prior $390M-$400M range
- 08/05/22
- Gogo reports Q2 EPS 17c, consensus 14c
- 05/05/22
- Gogo raises 2022 revenue view to $390M-$400M from $380M-$395M
- 09/16/22
- FirstEnergy sees FY22 results in upper half of guidance range
- 07/26/22
- FirstEnergy sees FY22 non-GAAP EPS $2.30-$2.50, consensus $2.40
- 07/26/22
- FirstEnergy sees Q3 non-GAAP EPS 70c-80c, consensus 80c
- 07/26/22
- FirstEnergy reports Q2 non-GAAP EPS 53c, consensus 53c
- $161.26 /
-43.74 (-21.34%) - 09/15/22
- FedEx sees Q2 EPS $2.65 or greater, consensus $5.48
- 09/15/22
- FedEx reports preliminary Q1 EPS $3.44, consensus $5.14
- 09/15/22
- FedEx pulls fiscal 2023 earnings forecast on 'volatile' environment
- 09/15/22
- FedEx withdraws FY23 guidance
- 08/02/22
- Extra Space Storage raises FY22 core FFO view to $8.30-$8.50 from $8.05-$8.30
- 08/02/22
- Extra Space Storage reports Q2 core FFO $2.13, consensus $2.04
- 05/03/22
- Extra Space Storage raises FY22 core FFO view to $8.05-$8.30, from $7.70-$7.95
- 05/03/22
- Extra Space Storage reports Q1 core FFO $2.01, consensus $1.86
- 07/15/22
- Citi reports Q2 EPS $2.19, consensus $1.68
- 07/14/22
- Notable companies reporting before tomorrow's open
- 06/20/22
- Fly Intel: Top five weekend stock stories
- 04/14/22
- Citi reports Q1 EPS $2.02, consensus $1.55
- 09/15/22
- Bowlero reports Q4 adjusted EBITDA $82.4M, up 94.8% y/y
- 07/15/22
- BlackRock reports Q2 adjusted EPS $7.36, consensus $7.90
- 04/13/22
- BlackRock reports Q1 adjusted EPS $9.52, consensus $8.84
- 08/04/22
- Arrow Electronics reports Q2 EPS $5.54, consensus $5.63
- 05/05/22
- Arrow Electronics sees Q2 EPS $5.48-$5.64, consensus $4.62
- 05/05/22
- Arrow Electronics reports Q1 EPS $5.43, consensus $4.56
ALHC Alignment Healthcare - 08/04/22
- Alignment Healthcare sees Q3 revenue $330M-$335M, consensus $331.14M
- 08/04/22
- Alignment Healthcare reports Q2 EPS(6c), consensus (26c)
- 09/15/22
- Adobe sees Q4 EPS $3.50, consensus $3.45
- 09/15/22
- Adobe reports Q3 EPS $3.40, consensus $3.33
- 06/16/22
- Adobe sees FY22 adjusted EPS roughly $13.50, consensus $13.66
- 06/16/22
- Adobe sees Q3 adjusted EPS roughly $3.33, consensus $3.40
- 07/20/22
- Alcoa reports Q2 adjusted EPS $2.67, consensus $2.31
- 07/20/22
- Notable companies reporting after market close
- 04/20/22
- Alcoa reports Q1 EPS $3.06, consensus $2.93
- 04/20/22
- Notable companies reporting after market close
|